Further, we used IGF-1 to activate the PI3K/AKT pathway and discovered that IGF-1 elevated tumor growth and weakened the tumor-suppressive effect mediated by ITGA11 knockdown in GC. The gene discussed is ITGA11; the disease is neoplasm.